Sanzyme

Sanzyme is a specialized biotechnology and pharmaceutical company based in India, recognized as a pioneer in the fermentation and probiotic industry. Originally established as Uni-Sankyo, a joint venture with Sankyo of Japan, the company focuses on the development and manufacture of probiotics, enzymes, and gonadotropins. Its flagship probiotic strain, Bacillus coagulans SNZ 1969, is widely used in gastrointestinal health and functional foods globally. In 2022, Sanzyme Biologics was acquired by JB Pharma, integrating its extensive portfolio of probiotics and reproductive health products into a larger pharmaceutical framework. The company maintains a strong presence in both domestic and international markets through its high-quality manufacturing and R&D capabilities.